Engineered heart slices for electrophysiological and contractile studies

Biomaterials

Volumn 55, Issue 1, 2015, Pages 119-128

  Blazeski, Adriana ^a   Kostecki, Geran M ^a   Tung, Leslie ^a  

^a Johns Hopkins University   (United States)

Author keywords

Cardiac tissue engineering; Cell culture; Electrophysiology; Extracellular matrix; Scaffold

Indexed keywords

ANISOTROPY; CELL CULTURE; CELL ENGINEERING; CELLS; CYTOLOGY; ELECTROPHYSIOLOGY; HEART; PHYSIOLOGY; RATS; SCAFFOLDS; SCAFFOLDS (BIOLOGY); SOAPS (DETERGENTS); TISSUE ENGINEERING;

CARDIAC TISSUE ENGINEERING; COMPLEX TOPOGRAPHIES; DECELLULARIZATION; ELECTRICAL CONDUCTION; EXTRACELLULAR MATRICES; NATIVE EXTRACELLULAR MATRIX; SODIUM CHANNEL BLOCKERS; VENTRICULAR CELLS;

TISSUE;

LIDOCAINE; DETERGENT;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ANISOTROPY; ARTICLE; CELL ELONGATION; CELL SURVIVAL; DNA CONTENT; ELECTRIC CONDUCTIVITY; ENGINEERED HEART SLICE; EXTRACELLULAR MATRIX; HEART; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE POTENTIAL; IN VITRO STUDY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING; TISSUE SLICE; ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL CULTURE; CHEMISTRY; CYTOLOGY; ELECTROPHYSIOLOGY; HEART ARRHYTHMIA; HEART CONTRACTION; HEART VENTRICLE; HEART VENTRICLE FUNCTION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PIG; PROCEDURES; TISSUE SCAFFOLD;

RATTUS; SUIDAE;

ANIMALS; ANISOTROPY; ARRHYTHMIAS, CARDIAC; CELLS, CULTURED; DETERGENTS; ELECTROPHYSIOLOGICAL PHENOMENA; EXTRACELLULAR MATRIX; HEART; HEART VENTRICLES; IN VITRO TECHNIQUES; LIDOCAINE; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; SWINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VENTRICULAR FUNCTION;

EID: 84932623227     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.03.026     Document Type: Article

References (50)

1. Hirt M.N., Hansen A., Eschenhagen T. Cardiac tissue engineering: state of the art. Circ Res 2014, 114:354-367.
2. Eschenhagen T., Eder A., Vollert I., Hansen A. Physiological aspects of cardiac tissue engineering. Am J Physiol Heart Circ Physiol 2012, 303:H133-H143.
3. Vunjak-Novakovic G., Eschenhagen T., Mummery C. Myocardial tissue engineering: invitro models. Cold Spring Harb Perspect Med 2014, 4:a014076.
4. Ott H.C., Matthiesen T.S., Goh S.-K., Black L.D., Kren S.M., Netoff T.I., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008, 14:213-221.
5. Wainwright J.M., Czajka C.A., Patel U.B., Freytes D.O., Tobita K., Gilbert T.W., et al. Preparation of cardiac extracellular matrix from an intact porcine heart. Tissue Eng Part C Methods 2010, 16:525-532.
6. Eitan Y., Sarig U., Dahan N., Machluf M. Acellular cardiac extracellular matrix as a scaffold for tissue engineering: invitro cell support, remodeling, and biocompatibility. Tissue Eng Part C Methods 2010, 16:671-683.
7. Oberwallner B., Brodarac A., Choi Y.-H., Saric T., Anić P., Morawietz L., et al. Preparation of cardiac extracellular matrix scaffolds by decellularization of human myocardium. JBiomed Mater Res Part A 2013, 102:3263-3272.
8. Williams C., Quinn K.P., Georgakoudi I., Black L.D. Young developmental age cardiac extracellular matrix promotes the expansion of neonatal cardiomyocytes invitro. Acta Biomater 2014, 10:194-204.
9. Lu T.-Y., Lin B., Kim J., Sullivan M., Tobita K., Salama G., et al. Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells. Nat Commun 2013, 4:2307.
10. Yasui H., Lee J.-K., Yoshida A., Yokoyama T., Nakanishi H., Miwa K., et al. Excitation propagation in three-dimensional engineered hearts using decellularized extracellular matrix. Biomaterials 2014, 35:7839-7850.
11. Lim Z.Y., Maskara B., Aguel F., Emokpae R., Tung L. Spiral wave attachment to millimeter-sized obstacles. Circulation 2006, 114:2113-2121.
12. Sathaye A., Bursac N., Sheehy S., Tung L. Electrical pacing counteracts intrinsic shortening of action potential duration of neonatal rat ventricular cells in culture. JMol Cell Cardiol 2006, 41:633-641.
13. Tapias L.F., Ott H.C. Decellularized scaffolds as a platform for bioengineered organs. Curr Opin Organ Transpl 2014, 19:145-152.
14. Akhyari P., Aubin H., Gwanmesia P., Barth M., Hoffmann S., Huelsmann J., et al. The quest for an optimized protocol for whole-heart decellularization: a comparison of three popular and a novel decellularization technique and their diverse effects on crucial extracellular matrix qualities. Tissue Eng Part C Methods 2011, 17:915-926.
15. Wang B., Borazjani A., Tahai M., Curry A.L.D.J., Simionescu D.T., Guan J., et al. Fabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cells. JBiomed Mater Res A 2010, 94:1100-1110.
16. Sarig U., Au-Yeung G.C.T., Wang Y., Bronshtein T., Dahan N., Boey F.Y.C., et al. Thick acellular heart extracellular matrix with inherent vasculature: a potential platform for myocardial tissue regeneration. Tissue Eng Part A 2012, 18:2125-2137.
17. Crapo P.M., Gilbert T.W., Badylak S.F. An overview of tissue and whole organ decellularization processes. Biomaterials 2011, 32:3233-3243.
18. Godier-Furnémont A.F.G., Martens T.P., Koeckert M.S., Wan L., Parks J., Arai K., et al. Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc Natl Acad Sci U S A 2011, 108:7974-7979.
19. Bowers S.L.K., Banerjee I., Baudino T.A. The extracellular matrix: at the center of it all. JMol Cell Cardiol 2010, 48:474-482.
20. Prestwich G.D. Simplifying the extracellular matrix for 3-D cell culture and tissue engineering: a pragmatic approach. JCell Biochem 2007, 101:1370-1383.
21. Fan D., Creemers E.E., Kassiri Z. Matrix as an interstitial transport system. Circ Res 2014, 114:889-902.
22. McCain M.L., Parker K.K. Mechanotransduction: the role of mechanical stress, myocyte shape, and cytoskeletal architecture on cardiac function. Pflugers Arch 2011, 462:89-104.
23. LaNasa S.M., Bryant S.J. Influence of ECM proteins and their analogs on cells cultured on 2-D hydrogels for cardiac muscle tissue engineering. Acta Biomater 2009, 5:2929-2938.
24. Jacot J.G., McCulloch A.D., Omens J.H. Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes. Biophys J 2008, 95:3479-3487.
25. Berry J.M., Naseem R.H., Rothermel B.A., Hill J.A. Models of cardiac hypertrophy and transition to heart failure. Drug Discov Today Dis Model 2007, 4:197-206.
26. Couade M., Pernot M., Messas E., Bel A., Ba M., Hagege A., et al. In vivo quantitative mapping of myocardial stiffening and transmural anisotropy during the cardiac cycle. IEEE Trans Med Imaging 2011, 30:295-305.
27. Kim D.-H., Lipke E.A., Kim P., Cheong R., Thompson S., Delannoy M., et al. Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proc Natl Acad Sci U S A 2010, 107:565-570.
28. Sekar R.B., Kizana E., Smith R.R., Barth A.S., Zhang Y., Marbán E., et al. Lentiviral vector-mediated expression of GFP or Kir2.1 alters the electrophysiology of neonatal rat ventricular myocytes without inducing cytotoxicity. Am J Physiol Heart Circ Physiol 2007, 293:H2757-H2770.
29. Kuo P.-L., Lee H., Bray M.-A., Geisse N.A., Huang Y.-T., Adams W.J., et al. Myocyte shape regulates lateral registry of sarcomeres and contractility. Am J Pathol 2012, 181:2030-2037.
30. Chung C.-Y., Bien H., Entcheva E. The role of cardiac tissue alignment in modulating electrical function. JCardiovasc Electrophysiol 2007, 18:1323-1329.
31. Weiss J.N., Karma A., Shiferaw Y., Chen P.-S., Garfinkel A., Qu Z. From pulsus to pulseless: the saga of cardiac alternans. Circ Res 2006, 98:1244-1253.
32. Bray M.-A.P., Adams W.J., Geisse N.A., Feinberg A.W., Sheehy S.P., Parker K.K. Nuclear morphology and deformation in engineered cardiac myocytes and tissues. Biomaterials 2010, 31:5143-5150.
33. Dalby M.J. Topographically induced direct cell mechanotransduction. Med Eng Phys 2005, 27:730-742.
34. Spach M.S., Heidlage J.F., Barr R.C., Dolber P.C. Cell size and communication: role in structural and electrical development and remodeling of the heart. Heart Rhythm 2004, 1:500-515.
35. Spach M.S., Dolber P.C. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res 1986, 58:356-371.
36. Bian W., Jackman C.P., Bursac N. Controlling the structural and functional anisotropy of engineered cardiac tissues. Biofabrication 2014, 6:024109.
37. Bursac N., Parker K.K., Iravanian S., Tung L. Cardiomyocyte cultures with controlled macroscopic anisotropy: a model for functional electrophysiological studies of cardiac muscle. Circ Res 2002, 91:e45-e54.
38. Kleber A., Janse M., Fast V. Normal and abnormal conduction in the heart. Handb Physiol Cardiovasc Syst Hear 2002, 455-530.
39. Bursac N., Kirkton R.D., McSpadden L.C., Liau B. Characterizing functional stem cell-cardiomyocyte interactions. Regen Med 2010, 5:87-105.
40. Schouten V.J.A., ter Keurs H.E.D.J. The force-frequency relationship in rat myocardium. Pflügers Arch 1986, 407:14-17.
41. oreno J.D., Zhu Z.I., Yang P.-C., Bankston J.R., Jeng M.-T., Kang C., et al. Acomputational model to predict the effects of class I anti-arrhythmic drugs on ventricular rhythms. Sci Transl Med 2011, 3. 98ra83.
42. Lu H.R., Rohrbacher J., Vlaminckx E., Van Ammel K., Yan G.X., Gallacher D.J. Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the "bad" sodium current blockers. Br J Pharmacol 2010, 160:60-76.
43. Anderson K.P., Walker R., Lux R.L., Ershler P.R., Menlove R., Williams M.R., et al. Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart. Circulation 1990, 81:1024-1038.
44. Tung L., Zhang Y. Optical imaging of arrhythmias in tissue culture. JElectrocardiol 2006, 39:S2-S6.
45. Feng C.H., Cheng Y.C., Chao P.H.G. The influence and interactions of substrate thickness, organization and dimensionality on cell morphology and migration. Acta Biomater 2013, 9:5502-5510.
46. Leong W.S., Tay C.Y., Yu H., Li A., Wu S.C., Duc D.H., et al. Thickness sensing of hMSCs on collagen gel directs stem cell fate. Biochem Biophys Res Commun 2010, 401:287-292.
47. Herpel E., Singer S., Flechtenmacher C., Pritsch M., Sack F.-U., Hagl S., et al. Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies. Virchows Arch 2005, 446:369-378.
48. Sullivan K.E., Quinn K.P., Tang K.M., Georgakoudi I., Black L.D. Extracellular matrix remodeling following myocardial infarction influences the therapeutic potential of mesenchymal stem cells. Stem Cell Res Ther 2014, 5.
49. Matsuura K., Masuda S., Shimizu T. Cell sheet-based cardiac tissue engineering. Anat Rec Hob 2014, 297:65-72.
50. Meyer T., Stuerz K., Guenther E., Edamura M., Kraushaar U. Cardiac slices as a predictive tool for arrhythmogenic potential of drugs and chemicals. Expert Opin Drug Metab Toxicol 2010, 6:1461-1475.